November 7, 2007 (Orlando, FL) – Using genetic tests as well as clinical factors improved the accuracy and efficiency of warfarin dose initiation, but the primary end point of a reduction in out-of- range INRs was not significantly changed in the overall population in the Couma-Gen study [1]. Subgroup analysis suggested, however, that pharmacogenetic guidance [...]
Filed under: Cytochrome P450, Personalized Medicine, Pharmacogenetics | Tagged: Coum-Gen, coumadin, Pharmacogenetics, randomized trial, study, warfarin | 2 Comments »
